Sue Naim

Ms. Naim joined ALX Oncology in July of 2020 and has served as our Senior Vice President of Clinical Operations since January 2024, and Vice President of Clinical Operations since June of 2022. Prior to joining ALX Oncology, Ms. Naim held roles of increasing responsibility in Clinical Operations at Astex Pharmaceuticals, a wholly owned subsidiary of Otsuka Pharmaceutical. Prior to Astex, she worked for Metabolex, Cell Genesys, PPD and ICN Pharmaceuticals. She has worked in the biopharmaceutical industry for over 20 years. Ms. Naim obtained her B.S. degree in Biochemistry from the University of California, Los Angeles.